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Abstract: The oxidation of lom efloxacin  (LO M ) and balofloxacin  (BA L) under the influence o f azo 
initiator of radical reactions of 4,4'-azobis(4-cyanopentanoic acid) (ACVA) and H 2O 2 w as exam ined. 
O xidation using H2O 2 w as perform ed at room tem perature w hile using ACVA at tem peratures: 40, 
50, 60 °C. Additionally, the oxidation process of BA L under the influence of K M nO 4 in  an acidic 
m edium  w as investigated. N ew  stability-indicating H PLC  m ethods w ere developed in order to 
evaluate the oxidation process. C hrom atographic analysis w as carried out u sing the K inetex 5u 
XB— C18 100A column, Phenomenex (Torrance, CA, USA) (250 X 4.6 mm, 5 pm particle size, core shell 
type). The chromatographic separation was achieved while using isocratic elution and a m obile phase 
w ith  the com position of 0.05 M  phosphate buffer (pH  =  3.20 adjusted w ith  o-phosphoric acid) and 
acetonitrile (87:13 v/v for LOM; 80:20 v/v for BAL). The column w as maintained at 30 °C. The methods 
were validated according to the IC H  guidelines, and it was found that they met the acceptance criteria. 
An oxidation process followed kinetics of the second order reaction. The m ost probable structures of 
LOM  and BAL degradation products form ed w ere assigned by the UH PLC/M S/M S method.
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1. Introduction
The stability of drugs is the one of the basic requirements, w hich is closely related to the efficiency 
of pharm acological action and safety of therapy. C hanges in the structure o f a chem ical com pound 
and physicochem ical properties m ay lead to a decrease in the therapeutic value of the drug through 
disturbances in the absorption process or a decrease in pharm acological activity or even increase in its 
toxicity. Therefore, the chem ical stability of pharm aceutical substances is a significant problem  that 
affects the safety and efficiency of the pharm aceutical preparation. The stability of the pharm aceutical 
active substance can be tested by  stress tests, long-term , interm ediate, and accelerated stability 
studies [1]. O xidation reactions are one of the two m ost com m on m echanism s of drug degradation in 
pharm aceutical system s [2- 4]. The reactions are typically autoxidative and its m echanism  consists of
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the formation of free radicals. Radical-initiated chain reactions start w ith an initiation phase (formation 
of radicals is rate-limiting), followed by a propagation phase and term ination phase [1,5 ]. The initiators 
of the oxidation chain reactions of the active substance m ay be chemical com pounds of various origin. 
There are m any exam ples, such as: peroxy (RO O *) and oxy (RO *) radicals derived from  the therm al 
haem olytic decom position of organic peroxides or photochem ical reactions; heavy m etal im purities 
from  the m anufacturing process; radiolysis or ozonolysis products. D escribed oxidation agents 
are often  contam inants of A ctive Pharm aceutical Ingredients (A PIs), excipients, or environm ental 
pollutants [3,4 ]. IC H  Q 1A  (R2) guidelines described conditions of stress tests w hich  depends on the 
drug substance and the type of m edicinal product [6]. However, the inform ation is general, there are 
no recommended oxidants or conditions for carrying out the oxidation process, and therefore there is a 
freedom in the planning of stress tests that a scientist can afford for scientific purposes [1]. One of the 
agents mentioned above is hydrogen peroxide, w hich is w idely used to study the oxidation of medicinal 
substances in stress testing. As a result of the oxidation of the API w ith the use of hydrogen peroxide, 
degradation products are often  form ed, w hich  can be form ed during long-term  decom position as 
minor impurities. This is not surprising that hydrogen peroxide and organic hydroperoxides belong to 
autooxidation products. O ther oxidizing agents used in stress testing are m etal ions, oxygen, and azo 
radical initiators, e.g., 2 ,2 '-azobisisobu tyronitrile (A IBN ) [4,7,8]. In  the case of hydrogen peroxide, 
it is recom m ended to condu ct the reaction at room  tem perature, because raising the tem perature is 
associated w ith the risk of the form ation of undesired hydroxyl radicals 2O H *. H ydrogen peroxide is 
often used, but it does not allow for the prediction of reactions involving molecular oxygen, w hich is a 
param agnetic d iradical in  its basic state; therefore, radical reactions are often  used as a good m odel 
for drug oxidation process. In  addition, stress testing using H2O2 often leads to secondary reactions 
of degradation of prim ary degradation products, thus hindering  the interpretation of the obtained 
results. Stress tests using hydrogen peroxide are useful for exam ining m edicinal products in w hich 
hydrogen peroxide occurs as an expected contam ination of excipients [2,4,9- 13]. Therefore, the test 
in the presence o f H2O2 should alw ays be carried out in parallel w ith  the radical in itiator test, as it 
provides com plem entary inform ation.
The initiators of radical reactions are azo com pounds, including 2 ,2 '-azobisisobu tyronitrile 
(A IBN ) and 4 ,4 '-azobis(4-cyanopentanoic acid) (ACVA), w hich  are w idely  used in  forced stress 
procedures [4,14,15]. Azo initiators have many advantages over standard organic peroxides, such as the 
fact that they form no oxygenated byproducts, only generating C-centered radicals, w hich are low energy 
and very selective [16]. Although AIBN  is used in organic synthesis usually at tem peratures betw een 
60 °C and 80 °C, its oxidation is carried out at a m uch lower temperature of 40 °C, as oxidation conditions 
should simulate long-term  degradation and allow for the isolation of labile degradation products, such as 
hydroperoxides that are destroyed at higher temperatures [4 ]. Boccardi et al. proposed azonitrile-based 
radical in itiators to study the autooxidation m echanism  of pharm aceuticals, dem onstrating that 
azonitrile-based compounds could produce primary oxidation/degradation products that were observed 
by long-term  storage of a drug and pharm aceutical forms [4,17]. W aterm an et al. [18] and H ovorka et 
al. [8 ] in the review of the oxidative degradation of pharmaceuticals have assumed that azonitrile-based 
radical initiators w ere useful to predict oxidation products by autooxidation. A lthough m any factors, 
such as: heat, light, and m etal catalysis prom ote initiation, initial radical form ation by  these m ethods 
is d ifficult to control experim ental param eters of the forced stress procedure, especially  in com plex 
pharm aceutical form ulations. For m echanistic purposes, the utilization of azo initiators allows for the 
quantitation of initial radical yields and it affords reproducible results with slightly elevated temperature 
or under controlled photolytic conditions. Alsante et al. recommended that free radical-based oxidation 
experim ents using azonitrile-based radical initiators should be conducted at all stages of development 
and provided the inform ation how  to carry  out forced degradation studies w hile using A IBN  and 
ACVA [19]. N elson et al. described the azonitrile initiator solutions as a good predictive m odel of the 
m ajor oxidative degradation products that w ere observed in pharm aceutical form ulations. A t low to
m oderate initiator concentrations, the degradation product distributions and degree of reactivity were 
sim ilar for sam ples that w ere stored in am bient and pressurized oxygen environm ents [14].
O ne of the specific, m ost prom ising, and intensely  studied drug groups in m odern antibiotic 
therapy, w hich w ell-know n from  the susceptibility for the degradation process are fluoroquinolones 
(FQs) [20- 22]. This group occupy a very  im portant place in  m odern  m edicine due to the broad 
spectrum of antibacterial activity, the possibility of oral and parenteral administration, good absorption, 
achieving high therapeutic concentrations in tissues and body fluids, rapid elim ination from the body, 
chem ical, and biological stability [23]. Lom efloxacin  (LO M ) and balofloxacin  (BA L) belong to the 
second and third generation of FQs class antibiotic, respectively. Balofloxacin and lom efloxacin inhibit 
both  the synthesis o f bacterial D N A  by  the suppression of the enzym e D N A  gyrase. In  addition, 
the bactericidal action of LOM and BAL results from the inhibition of topoisomerase IV, w hich is needed 
for the transcription and replication of bacterial DNA [24]. The degradation studies on LOM have been 
perform ed w hile using different oxidation agents: H 2O 2/UV, alkaline perm anganate, perm anganate 
in acidic m edium  and catalytically  activated persulfate, in few  cases the degradation products w ere 
separated and identified by LC-M S [25- 28]. In the available literature, there is no inform ation regarding 
hydroxyl-radical induced oxidation of B A L or in  the presence of H 2O 2, although several studies are 
focused on its photooxidation process [29,30].
The aim of this study w as to evaluate the oxidation of LOM  and BAL under the influence of azo 
initiator of radical reactions of ACVA and hydrogen peroxide, and to com pare both of the processes. 
The oxidation of BA L under the influence of K M nO 4 in  an acidic m edium  has not been  extensively 
described in the literature, so it w as decided to also investigate this process. In  order to achieve the 
above goals, new  H PLC -D A D  m ethods allow ing for the determ ination of LO M  and BA L next to 
oxidation products were developed and validated. The kinetic evaluation of the oxidation process was 
perform ed, and the degradation products w ere identified by  the U H PLC -M S/M S m ethod. It seem s 
that the research w e have undertaken has a cognitive and application value, because, in the available 
literature, we have not found com prehensive research on the oxidative degradation of LOM  and BAL 
in the presence of oxidants that w ere selected by us.
2. Results and D iscussion
2.1. Optimization o f  Chromatographic Conditions
The usefulness of m obile phases containing 0.05 M  phosphate buffer w ith  pH  =  3.20 and 
acetonitrile in various proportions (80:20, 85:15, 87:13, v/v) w as checked in order to develop an 
appropriate chrom atographic m ethod to separate BAL or LOM  from their oxidation products.
The solutions of the tested FQ s after 48  h of incubation at 50 °C in 10 m M  ACVA, after 72 h 
incubation in 3%  H 2O 2 and after 1 h of incubation in acid ic m edium  w ith  the presence o f K M nÜ 4 
w ere used for the analysis. O n the basis of the obtained chrom atographic param eters, such as peak 
symmetry, resolution factor, and retention tim e, the buffer/acetonitrile m ixtures 80:20 (v/v)  and 87:13 
(v /v)  w ere selected in order to evaluate the oxidation of BAL and LOM , respectively.
2.2. M ethod Validation
The developed H PLC  m ethods m eet the acceptance criteria for the specificity. In the proposed 
chrom atographic conditions, w ell shaped peaks w ere obtained for exam ined FQ s and oxidation 
products. The satisfactory resolution w as also guaranteed both for peaks of m ain substances and 
degradation products. The values of the separation factors obtained for the closest adjacent degradation 
product and the tested FQ w ere greater than 2.5. M oreover, at the analytical w avelength, the ACVA 
control sam ple did not give additional peaks in the chrom atogram , w hich could interfere w ith peaks 
of oxidation products (Figure 1).
Figure 1. Chromatograms of the 4,4'-azobis(4-cyanopentanoic acid) (ACVA) control samples after 
incubation for 48 h at 60 °C recorded sit: (A)—12*95 nm, (B)—280 nm.
As a result of the regression analysis, it was stated that the obtained param eters fitted w ell to the 
linear m odel of relationship in studied concentrations range. The correlation coefficients; and obtained 
determ ination coefficients w ere greater than 0.99. The y-intercepts of the linear equation for BAL and 
LO M  w ere statistically  insignificant. p-values of the Shapiro-W ilk norm ality  test w ere greatef than 
0.06 w hat confirm s tires norm al distribution of tire residuals. Linearity range w as obtained in the w ide 
conrentration range (0.05-S.18 mg-mL-1 for LOM  and 0.05-0.26 mg-mL-1 for B A L ) Table 1 presents all 
of the described regression analysis results.
Table 1. Validation of the; mehhod.
Parameter BAL LOM
tR (min) a 10.03 ± 0.41 14.50 ± 0.27
LOD (mg-mL-1) 0.0117 0.0138
LOQ (mg-mL-1) 0.0355 0.0419
Linear range (mg-mL-1) 0.05-0.26 0.05-0.18
Regression equation (y): Slope (a ± Sa) 1861 X 105 ± 2,842,634 1708 X 105 ± 4,792,179
Intercept (b ± Sb) -989,217 ± 492,253 1,078,726 ± 581,021
u -2.02 < ta f 1.86 < t f
Normality of residuals b (Shapiro-Wilk test) 0.9319 (p = 0.47) 0.9399 (p = 0.49)
Correlation coefficient r 0.9991 0.9961
Determinalion coefficient r2 0.9981 0.9922
Precisinn (% RSD) 0.17 0.38
Intermediate precision (% RSD) 0.64 0.83
a Mean ± SD (n = 6); LOD—limit of detection, LOQ—limit of quantification; Regression equation y = ac + b; 
c—coneentration of solution; y—peak area; Sa—standard deviation oU slope; Sib—standard deviation of intercept; 
t—calculated value ef Student's t-tesr, ta f = 2.776 critical value of Student's t-test for degrees of freedom f = 4 and 
significance level a  = 0.05; b normal distribution of residuals if p > 0.05.
Based on the LOD  and LOQ  values, w hich w ere found to be from 0.0138 to 0.0419 m g-m L-1 and 
from 0.0081 to 0.0172 mg-mL-1 , for LOM  and BAL, respectively, it w as assum ed that the m ethod w as 
characterized by a good sensitivity. G ood precision and interm ediate precision w ith % RSD  less than 
0.83% were obtained (Table e). A slight change (±5%  from the optimel value:) in the composition of the 
m obile phase caused significant changes in the quality oh the chrom atographic separation that w ere 
related ho the appearance arid shape of the obtained peaks. Therefore, it is im portant tea m aintain  a 
constant eatio of bufler and scetonitrile in p m obile phase.
2.3. Oxidation o f  Exam ined FQs
The data on the influence of the solvent on the oxidation process w ith ACVA have been found in 
the available liternture i31]. Takin g the above m form ation in to account, a m ethanohc and aqueous 
solutions of LOM were prepared and analyzed. Due to the fact that BAL is insoluble m wrter, only the 
m ethanol solution w as prepared foe tesSing.
The oxidation of BA L and LO M  u ring  the radical in itiator ACVA has been  tested in solutions 
incubated at 40 °C, 50 °C, and 60 °C. Likew ise, the oxidation process of BAL and LOM  after reaction 
w ith com m only used hydrogen prrooide at room tem perature (RT) w as exam ined.
The oblained rerults dem oostrated that the coarse of the oxidatinn process depends on the type 
of FQ s, incubalion  tim e, temppraeure, and the oxidizing agent used-. Increaring the incubation tim e 
and tem perature resulted in an inrreese ini the degradation of the tested oompounds.
The percentage o f BA L degradation under the influence hf ACVA after t4 4  h of incubation at 
40 °C  w as 16.31°%, after 48 h  oI incubotion a t 50 °C  w as 18.34%  and after 48 h  of incubation at 60 °C 
w as 36.76% . The oxidation of BAL by ACVA led to tire aormation oh tw o m gin degradation products 
(tR ~  5. 40 min and 130-30 min) and the rout others w ith a sm all am ount (<0.7% ) (Figures 2- 4 ).
Figure 2. Chromatogram of balofloxacin (BAL) after oxidation by ACVA at 40 °C after incubation 
for 144 h.
M inutes
Figure 3. Chromatograms of BAL after oxidation by ACVA at 150 °C. Incubation time: (A)—36 h, 
(B)—48 h.
Figure 4. Chromatogram of BAL after oxidation by ACVA at 60 °C. Incubation time—48 h.
The percentage of LOM  degradation (methanolic solution) at 40 °C after 216 h of incubftion was 
20.62% , at 50 °C after 96 h— 36.76% , w hile at 60 °C  a sim ilar percentage of degradation (38.55% ) w as 
already observed after 4118 h o f incubation.
The use of ACVA and presence of m tthanol resulted in the formation of three main LOM  products 
(tR p 8.78 min, 12.70 min, and 47.30 min). M oreovor two additional oxidation producfs tamount <  0.8%) 
w ith  retention tim es of 11.74 m in and 52.26 m in w ere registered at tem perature 60 °C  and 50 °C, 
respectively. Figure 5 show s exem plary chrom atogram s.
Figure 5. Chromatograms of methanolic solution of lomefloxacin (LOM) after oxidation by ACVA: 
(A)—40 °C and 216 h of incubation, (B)—150 °C and 96 h of incubation, (C)—60 °C and 48 h of incubation.
In  turn, the results of oxidation of LO M  (aqueous solution) by  ACVA show ed that the absence 
of m ethanol in the solution accelerates the process and causes the form ation of as m any as eight 
degradation products. A fter 96  h  of incubation at 40 °C , the percentage of degradation of LO M  'was 
14.28%, a(ter 72 hi at 50 °C, 43.96% , and sit (60 °C, after 36 h, 34.17%> (Figure 6).
Studies w ith  3°% H 2O 2 show ed 6hat the degradation of LO M  w as ilow er than BAL, after 96 h  of 
incubation its degradation w as 5.88%  and after 168 h incubation it increased to 8.13% . In contrast, 
the oxidation degradation of BA L after 96 h w as 17.3%. The oxidation process of LO M  led to the 
form ation of one of the m ain degradation products (tR =  5.34 m in) and the tw o others w ith  a sm all 
am ount (tR =  9.61 m in and 10.0 m in) (Figure 7 ). O nly one product w as form ed as a result of the 
oxidation of BAL (Figure 8 ).
Figure 6. Chromatograms of water solution of LOM after oxidation by ACVA: (A)—40 °C and 96 h of 
incubation, (B)—50 °C and 72 h of incubation, (C)—60 °C and 36 h of incubation.
Figure 7. Chromatogram of LOM after oxidation by H2O2 after incubation for 168 h.
Figure 8. Chromatogram of BAL after oxidation by H2O2 after incubation for 72 h.
In  our previous w ork, w e described the oxidation of LO M  under the influence of K M nO 4 [27], 
bu t w e did not condu ct such studies for BA L. Therefore, the oxidation process of BA L under the 
influence of KM nÜ 4 in an acidic environm ent at RT w as additionally investigated.
Theo oxidation procest of BAL under the influence of KM nO4 was very fast and, after one hour of 
incubation, the percentage of FQ degradation was 56.26. The process led to the formation of one major 
degradation product (tR =  9.12 min) and three sm aller ones (tR =  4.66; 15.60; 19.81 min) (Figure 9).
Figuret 9. Chromatogram of BAL after oxidation by KMnO4 in the acidic medium afier incubation for 
1 h at RT.
2.4. Kinetic Evaluatfon
The analysis of the plots 1/c =  f(t) for both  the oxidation of BA L and LO M  w hile using ACVA 
and H 2O 2 dem onstrated a highly  significant correlation w hich confirm ed that the oxidation process 
followed the kinetics of second order reaction (Figures 10- 12). The kinetic param eters of the oxidation 
reactions, such as degradation rate constant k and half-life fo.5 w ere calculated  for all exam ined 
conditions (Tables 2 and 3 ).
" V  LOMMeOH 40°C  
^  LOMmeoh50°C 
X  LOMMeOH60°C  
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Figure 10. The 1/c = f(t) graph of oxidation of aqueous and methanolic LOM solutions under the
influence of ACVA.
t [h] \  BAL 60°C
Figure 11. The 1/c = f(t) graph of oxidation of BAL under the influence of ACVA.
Figure 12. The 1/c = fft) graph of oxidation of examined fluoroquinolones (FQs) by H2O2 and BAL 
by KMnO4 .
Table 2. The kinetic results of the FQs oxidation by ACVA.




0.13 x 10-4 769.2 0.9920
50 0C 0.42 x 10-4 238.1 0.9985




0.14 x 10-4 714.3 0.9874
50 0C 0.10 x 10-3 100.0 0.9940




0.11 x 10-4 909.1 0.9893
50 0C 0.58 x 10-4 172.4 0.9568
60 0C 0.10 x 10-3 100.0 0.9778
k—rate constant, r—correlation coefficient.
Table 3. The kinetic results of the oxidation of FQs by H2O2 and KMnO4.










LOM RT h 2o 2 0.46 x 10-5 2173.9 0.9928
k—rate constant, r—correlation coefficient, RT—room temperature.
The calculated kinetic parameters for the oxidation process for individual FQs suggest that the rate 
of the oxidation process is dependent on the oxidation agent used, the type of FQ tested, tem perature, 
and for a reaction involving ACVA also on the presence of m ethanol in the tested sam ple (Tables 2 
and 3) .
U nder the conditions of the experim ent, the oxidation of LO M  and BA L under the influence 
of ACVA proceeded faster w ith  an  increasing tem perature. There w ere no differences in  the rate 
of oxidation reaction for m ethanolic LO M  and BA L solutions a t the tem perature of 60 0C, bu t they 
appeared at the tem peratures o f 50 0C and 40 0C. The k inetic param eters of the LO M  oxidation 
process under the influence of ACVA also indicate that, for all tested tem peratures, it runs faster 
for w ater solutions than for m ethanolic solutions (Table 2) . The explanation for this phenom enon 
m ay be the study described in the w ork of N elson at el. They suggested that, w hen using ACVA or 
AIBN  as oxidants, alkoxy radicals are actually a significant source of the observed oxidizing reactivity. 
The presence of 5-10%  methanol in the reaction mixture significantly quenches alkoxy radical reactivity, 
reducing the degradation rate of API. The observed effect is due to the preferential removal of H atoms 
from m ethanol and its trace im purities by alkoxy radicals [31].
The oxidation process of the tested FQ s under the influence o f hydrogen peroxide show ed 
significant differences. The oxidation of BA L w as about 5.8 tim es faster than that of LOM . 
W hen oxidizing LO M  w ith  hydrogen peroxide at RT, a significant difference w as observed w hen 
com pared to u sing ACVA at 40 °C. The oxidation of both  the aqueous and m ethanolic solutions of 
LO M  by ACVA proceeded m uch faster than the oxidation by H 2O2. A dditionally, w hile taking the 
oxidation of LOM by KMnO4 at pH 4.5 described in the literature into account [27], it can be concluded 
that this oxidizer causes that the process is much faster (t0.5 =  2.2 h) than under the influence of ACVA 
at 40, 50 and 60 °C.
In  the case of BA L, oxidation under the influence of ACVA at 40 °C  w as slow er than under the 
influence of H 2O 2 at RT; however, at the other tem peratures of 50 °C and 60 °C, it w as faster (Tables 2 
and 3 ). The oxidation process of BAL by KM nO4 in an acidic environm ent at RT was also investigated 
(Table 3) . The obtained results indicate that oxidation by KM nO4, as in the case of LOM, is much faster 
(t0.5 =  1.1 h) than under the influence of H 2O 2 (t0.5 =  370.4 h) or ACVA at 60 °C (t0.5 =  100.0 h).
2.5. Identification o f  Oxidation Products
The identification of degradation products of exam ined FQ s w as perform ed on a basis of 
U H PLC -M S/M S analysis and supported by fragm entation patterns that w ere obtained from  M S/M S 
experim ents. The degradation products are show n in Tables 4 and 5 .
Table 4. Proposed structures of the degradation products of BAL.
Compound
Oxidizer
tR(min) IM +  H+] Fragmentation Oons Stracture
O O
BP-1 KM n04 2.34 40-4.2? 20-4.1,232.1, 247.1, 257.1,2?7'3l.:i, 3f̂  62.2
BP-2 KM n04 2.91 404.2
















KM n04 4.25 293.1
149.1.179.1, 205.1,
219.1, 235.1, 275.1
a retention times recorded by UHPLC-MS/MS.
Table 5. Proposed structures of the degradation products of LOM formed under the influence of ACVA.
rRCompoulid (mRn) [M +  H+] Fragmentation Ions S tructure
LOM 2.92 352.1
194.0, 208.1, 223.1, 
237.1,251.1, 265 .1, 
290.1,306.1,334.1
LP-1 4.10 2(59.1 140.0,167.0,195.1, 223.1, 251.1
LP-2 4.71 285.1 156.1,214.1, 2-42.1, 270 .1
LP-3 4.76 380.1 249.1,263.1, 30(5.1, 334.1, 3652. .1
In  our previous w ork, w r published the resultd od oxidation of0 LO M  by K M n0 4  [27]. In this 
study, the oxidation of BA L w hile ueing KMnOy in an acidic m edium  at RT w as also checked and it 
w as possible to try to determ ine the m ost probable structures of oxidation products. These products 
w ere com pared wiith those that w tre  obtained by  oxidation w ith  ACVA and H 20 2 . The results are 
sum m arized in Table 4 . The degradation process w as found to affect 3-(m ethylam ino)piperid ine 
m oiety of iA L . ln  the case of degradation with H 2O 2, it seems, ahat the oxidation of the ring led to its 
opening yielding BP-4 . Degradation w ith KM nO.4 yrelded more products of 3-lm ethylam ino)piperidine 
oxidation (BP-1- B P-3), leading finally -to BP-5 . Degradation w ith free radicals generating agent ACVA 
yielded sim ilar products to KM n0 4  oxidation, but in a lesser amount (BP-31, BP-5). The fragm entation 
patterns of BAL and its degradation products are show n in Schem es 1- 6.
Scheme 1. Proposed fragmentation pattern of BAL.
Scheme 2. Proposed fragmentation pattern of BP-1.
Scheme 3. Proposed fragmentation pattern of BP-2.
Scheme 4. Proposed fragmentation pattern of BP-3.
Scheme 5. Proposed fragm enta tion  pa tte rn  of BP-4.
Scneme 6. Proposed rragmentation pattern or Br-5.
In  the: case of LO M  degradation process w ith  ACVA w as found to affect m ainly 
3-(methyl)piperazine moiety, leading to its oxidation (LP-3) with further ring; cleavage (LP-1 and LP-2). 
Additionally, for- the product LP-2 hydration of pyridin-4-one m oiety w as observed (Table 5 ). In the 
case of LOM  degradation under the influence of H f O 2, the chem ical structure of the resulting product 
has not been established. The fragm entation patterns of LOM and its de°radation produots are shown 
in Schem es 7- 10.
Scheme 7. Proposed fragmentation pattern of LOM.
Scheme 8. Proposed fragmentation pattern o f  LP-1.
Scheme 9. Proposed fragmentation pattern of LP-2.
Scheme 10. Proposed fragmentation pattern of LP-3.
If: m ay be assumed that this d egradati on w ith ACVA due to generati on of ROS (Re active Oxygen 
Species) yields similar products to those that were observed for1 K M n 0 4, but in a less er amount. /At the 
same time the degradation with H 20 2 yields products with a lower degree of oxidation, probably due 
to the low er redox; potential.
A dditionally, the toxicity  risk assessm ent of described degradation products w as estim ated 
based on their structure w hile using O siris Property Explorer (https://w w w .organic-chem istry.org/). 
Fortunately, none of them  show  m ore risks than prim al substance.
3. M aterials and Methodis
3.1. Chemicals and. Reagents
Balofloxacin  (Cat. N  o. SZ BD 078XV ); Lom efloxacin  hydrochloride (Cat. No. 129K2157) 
and (4,4'-anbis(4-cyanovaleric acid) (ACVA) w ere purchased from  Sigm a-A ld rich  (Steinheim , 
G erm any). H PLC  grad e  m ethanol and acetonitrile vs ere purchased from  W ITK O  (Łódz, Poland).
H ydrogen peroxide 30% , sodium  dihydrogen phosphate anhydrous and orthofosforic acid (85%), 
and HPLC grade w ater w ere purchased from M erck (Darm stadt, Germ any).
3.2. Standard Solution
The amount of 0.1000 g of each FQs was weighed on analytical balance. LOM was dissolved in the 
volume of 50 mL of water or methanol, and filled up to the 100 mL with the same solvent. The weighed 
sam ple of BAL w as d issolved in the volum e of 80 m L of m ethanol, and then filled up to the 100 mL 
w ith the sam e solvent.
For m ethod validation, solutions containing different concentrations of the exam ined FQs in the 
range 0.05-0 .18 m g-m L-1 for LOM  and 0.05-0 .26 m g-m L-1 for BAL w ere prepared.
3.3. H PLC— DAD Analysis
The liquid chrom atography system , H ITACH I, H igh-Technologies C orporation (Tokyo, Japan) 
equipped w ith  a solvent delivery pum p (L-2130), degasser, an autosam pler (L-2200), a photodiode 
array detector (L-2455), and a colum n oven (L-2350) w as used. The chrom atographic analysis of 
chosen substances w as perform ed on Kinetex 5u XB— C18 100A colum n, Phenom enex (Torrance, CA, 
U SA ) (250 X 4.6 m m , 5 pm particle size, core shell type), coupled w ith  guard-colum n. The colum n 
temperature w as 30 °C. The chromatographic separation was achieved using as a mobile phase mixture 
of 0.05 M phosphate buffer (pH =  3.20 adjusted w ith o-phosphoric acid) and acetonitrile (87:13 v/v for 
LOM; 80:20 v/v for BAL). The flow rate of the m obile phase w as 1.0 mL-min-1 , and the injection volume 
was 10 pL. The analysis time was 55 min for LOM and 40 min for BAL. The samples were monitored at 
280 nm for LOM  and at 295 nm for BAL.
3.4. UPLC/MS/MS Analysis
The U PLC-M S/M S system  consisted of a W aters A CQ U ITY UPLC (Waters C orporation, M ilford, 
M A , U SA ) coupled to a W aters TQ D  m ass spectrom eter (electrospray ionization m ode ESI-tandem  
quadrupole). Chrom atographic separations w ere carried out using the A cquity UPLC BEH  (bridged 
ethyl hybrid) C 18 colum n; 2.1 X 100 m m , and 1.7 pm particle size, equipped w ith Acquity UPLC BEH 
C18 VanGuard pre-column; 2.1 X 5 mm, and 1.7 pm particle size. The column was maintained at 40 °C 
and eluted under gradient conditions using from 95% to 0% of eluent A over 10 m in, at a flow rate of 
0.3 m L-m in-1 . Eluent A: 0.1%  w ater solution of form ic acid; eluent B: 0.1%  solution of form ic acid in 
acetonitrile. C hrom atogram s w ere recorded w hile using  W aters eA PD A  detector. The spectra w ere 
analyzed in 200-700 nm  range w ith 1.2 nm resolution and sam pling rate 20 points/s.
M S detection settings of W aters TQ D  m ass spectrom eter w ere as follow s: source tem perature 
150 °C, desolvation tem perature 350 °C, desolvation gas flow rate 600 L-h-1 , cone gas flow 100 L-h-1 , 
capillary potential 3.00 kV, and cone potential 30 V. Nitrogen w as used for both nebulizing and drying 
gas. The data w ere obtained in a scan m ode ranging from  50 to 1000 m/z in tim e 0.5 s intervals; 
eight scans w ere sum m ed up to get the final spectrum . In  M S/M S experim ents collision energy w as 
set to 50 eV  and argon w as used as a collision gas. D ata acquisition softw are w as M assLynx V  4.1 
(Waters (Milford, M A, USA)).
3.5. M ethod Validation
The proposed m ethod w as validated for the determ ination of BAL and LO M  in  the presence of 
oxidation products by HPLC analysis according to ICH guidelines [6]. In order to assess the specificity 
of the new HPLC m ethods the 0.5 mM solutions of BAL and LOM after reaction with chosen oxidizers 
were analyzed. Oxidation study was performed in 10 mM ACVA solution heated at 50 °C; the solution 
w as left for 48 h, in 3%  H 2O 2 after 72 h of incubation and in acidic m edium  w ith  the presence of 
KM nO 4 after 1 h of incubation.
The linearity  for BA L and LO M  w as determ ined preparing five solutions that covered the 
concentration range of 0 .05-0 .26  m g-m L-1 for BAL and 0 .05-0 .18  m g m L -1 for LOM . The correlation
coefficient, determ ination coefficient, slope of the regression line and standard deviation of slope, 
y-intercept and standard deviation of intercept, and also standard error of residuals of the calibration 
curve w ere calculated w hile u sing Statistica 13.3 (TIBC O  Softw are Inc., Palo A lto, C A , USA ). 
The Shapiro-W ilk statistical test was also done. Based on the formula LOD =  3.3 Se/a and LOQ =  10 Se/a, 
the LO D  and LO Q  for exam ined FQ s w as calculated. The values of LO D  and LO Q  w ere then 
experim entally confirm ed.
The six separately prepared solutions w ere analyzed to check the precision of the m ethod at the 
concentration level 0.10 m g-m L-1 for BA L and LO M . The sam e procedure w as follow ed for three 
another days by  different analysts to exam ine the interm ediate precision of the described m ethods. 
The precision and the interm ediate precision w ere then assum ed by the calculated RSD  (%) value of 
the peak area of tested FQ s. The contents of m obile phase w ere m ade intentionally  in  order prove 
the robustness of the proposed m ethods sm all m odifications o f flow  rate. To check the effect of the 
flow rate on resolution, the flow rate w as changed to 1.10 and 0.90 m L-m in-1 (prim ary flow rate w as 
1.0 m L-m in-1 ). The tem perature of the colum n w as m odified to 28 °C  and 32 °C  (instead of 30 °C), 
and the com position of the m obile phase w as changed ±5%  from the initial value.
3.6. Preparation o f  Samples and Execution o f  Oxidation Tests with the Participation o f  ACVA
The test sam ples w ere prepared, as follow s: the appropriate volu m e of a 1 m g-m L-1 solutions 
of BA L or LO M  w as added to 25 m L volum etric flask and filled up w ith  10 m M  w ater-acetonitrile 
(50:50 v/v) solution of ACVA to obtain a concentration of FQ of 0.5 mM . N ext, 2.0 mL of this prepared 
solution w as added to the 2.0 m L vials. Additionally, an ACVA control sam ples that did n ot contain 
F Q  and control sam ples of fluoroquinolone w ithou t ACVA solution w ere prepared in 2.0 m L vials. 
A ll of the sam ples w ere then closed tightly w ith a stopper and a cap and incubated in heating blocks 
(QBH2 Grant, Grant Instrum ents), set at temperatures 40 °C, 50 °C and 60 °C. The samples of BAL were 
incubated at 40 °C  for 144 h; at 50 °C  and 60 °C  for 48 h. The sam ples of LO M  (w ater solution) w ere 
incubated at 40 °C  for 96 h, at 50 °C  for 72 h  and at 60 °C  for 36 h. The sam ples of LO M  (m ethanolic 
solution) were incubated at 40 °C for 216 h, at 50 °C for 96 h and at 60 °C for 48 h. At appropriate time 
intervals w hich  w ere m ainly dependent on the type of F Q  and tem perature, the content of one vial 
w as analyzed in duplicate.
3.7. Preparation o f  Samples and Execution o f  Oxidation Tests with the Participation o f  3% H2O2
The test sam ples were prepared, as follows: the appropriate volum e of a 1.0 mg-mL-1 solution of 
BA L or LO M  w as added to 25 m L volum etric flask and filled up to the final volum e w ith  3%  H 2O 2 
solution to obtain the final concentration of FQ of 0.5 mM. N ext, 2.0 mL of this prepared solution was 
added to the 2.0 mL vials.
A ll o f the sam ples w ere then closed tightly  w ith  a stopper and a cap and incubated in  room  
temperature. The samples of BAL were incubated at RT for 72 h. The samples of LOM (water solution) 
w ere incubated at RT for 168 h. A t appropriate tim e intervals w hich  w ere m ainly dependent on the 
type of FQ  and tem perature, the content o f one vial w as analyzed. The analyses w ere perform ed 
in duplicate.
3.8. Preparation o f  Sample o f  BAL and Execution o f  Oxidation Tests with the Participation o fK M n O 4
The sam ple of BAL was prepared in the same way described in our w ork regarding the influence 
of K M n 04 on the LOM [27]. An acetate buffer pH 4.5 was used in the study. After 1 5 ,3 0 ,4 5 , and 60 min 
of incubation at RT, the tested sam ples w ere analyzed by HPLC.
3.9. D eterm ination o f  Kinetic Param eters o f  the Oxidation Process
In order to determine the order of the reaction, ln c or 1/c dependence curves were plotted against 
the incubation tim e, and then the fit to the linear m odel w as checked and the correlation coefficients
w ere determ ined. The sym bol c represents the percent of rem aining non-degraded FQ. Subsequently, 
the reaction rate constants (k) and degradation tim es of 50% for the tested FQs (t0.5) w ere calculated.
4. Conclusions
The oxidation process of BAL and LOM  under the influence of an azonitrile radical initiator, i.e., 
ACVA at 4 0 ,5 0 , and 60 °C, and hydrogen peroxide w ere investigated. Additionally, the oxidation of 
BAL under the influence of KMnO4 in an acidic environment w as assessed. The oxidation process was 
estimated while using newly developed HPLC m ethods that were validated. The oxidation reactions in 
the presence of ACVA, H 2O2, and KM nO4 followed the kinetics of the second-order reactions. Based on 
the conducted research and literature data [27], it was found that the FQs oxidation process is the fastest 
as a result of K M n 0 4 in an acidic environm ent. The profile of the resulting degradation products of 
BAL is similar to the profile that w as obtained under ACVA. The profiles of LOM degradation products 
produced under the influence of K M N 0 4 [27] and ACVA were different. W hereas under the influence 
of hydrogen peroxide, the m ost frequently used in drug stability studies, only one product w as formed. 
W hile using the U H PLC -M S/M S m ethod, the probable structures of the oxidation products of the 
tested FQs w ere established, w hich w ere not previously described in the literature.
It seem s that the use of other oxidants in stress tests, apart from  H 2O 2, is fully justified  and 
should be recom m ended due to the obtained results. In addition to the value of scientific knowledge, 
the research undertaken is of practical im portance for the technology of the drug form , the aim  of 
w hich is to obtain stable, safe, and effective drugs.
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